Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$98.98 - $115.74 $2.46 Million - $2.88 Million
-24,900 Reduced 2.13%
1,143,800 $132 Million
Q2 2023

Aug 14, 2023

BUY
$96.34 - $112.38 $76.2 Million - $88.9 Million
791,200 Added 209.59%
1,168,700 $120 Million
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $79.8 Million - $84.4 Million
-743,500 Reduced 66.32%
377,500 $41.2 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $60.1 Million - $110 Million
963,500 Added 611.75%
1,121,000 $128 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $8.99 Million - $12.9 Million
152,500 Added 3050.0%
157,500 $9.75 Million
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $9.53 Million - $14 Million
-120,000 Reduced 96.0%
5,000 $399,000
Q1 2022

May 13, 2022

SELL
$86.42 - $109.81 $4.51 Million - $5.73 Million
-52,200 Reduced 29.46%
125,000 $13.2 Million
Q4 2021

Feb 11, 2022

SELL
$98.56 - $119.91 $14.4 Million - $17.5 Million
-145,700 Reduced 45.12%
177,200 $19.1 Million
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $15.6 Million - $18.8 Million
169,900 Added 111.05%
322,900 $35.4 Million
Q2 2021

Aug 16, 2021

SELL
$86.24 - $95.92 $20.2 Million - $22.5 Million
-234,700 Reduced 60.54%
153,000 $14.3 Million
Q1 2021

May 17, 2021

BUY
$71.83 - $95.48 $22.8 Million - $30.4 Million
318,000 Added 456.24%
387,700 $35.7 Million
Q4 2020

Feb 16, 2021

SELL
$67.0 - $84.39 $2.03 Million - $2.56 Million
-30,300 Reduced 30.3%
69,700 $5.1 Million
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $5.52 Million - $7.99 Million
100,000 New
100,000 $7.77 Million
Q1 2020

May 15, 2020

SELL
$24.87 - $38.56 $248,700 - $385,600
-10,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$23.0 - $27.97 $230,000 - $279,700
10,000 New
10,000 $272,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.